(Q42622024)

English

Long-term effects of rivastigmine treatment on the need for psychotropic medications in nursing home patients with Alzheimer's disease : results of a 52-week open-label study

scientific article published on January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 November 2017

Long-term effects of rivastigmine treatment on the need for psychotropic medications in nursing home patients with Alzheimer's disease : results of a 52-week open-label study (English)

1 reference

Europe PubMed Central

3 November 2017

Alzheimer's disease

0 references

author name string

Keith Edwards

1

1 reference

Europe PubMed Central

3 November 2017

Barbara Koumaras

2

1 reference

Europe PubMed Central

3 November 2017

Michael Chen

3

1 reference

Europe PubMed Central

3 November 2017

Ibrahim Gunay

4

1 reference

Europe PubMed Central

3 November 2017

Dario Mirski

5

1 reference

Europe PubMed Central

3 November 2017

Rivastigmine Nursing Home Study Team*

6

1 reference

Europe PubMed Central

3 November 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

3 November 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

3 November 2017

25

1 reference

Europe PubMed Central

3 November 2017

507-515

1 reference

Europe PubMed Central

3 November 2017

8

1 reference

Europe PubMed Central

3 November 2017

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer Disease in the US Population

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of atypical antipsychotic drugs in patients with dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychotropics and drug interactions in the elderly patient.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The spectrum of behavioral changes in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stage-specific prevalence of behavioral symptoms in Alzheimer's disease in a multi-ethnic community sample.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine (Exelon) for dementia in patients with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of psychopharmacologic agents in the elderly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine in vascular dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Appropriate use of psychotropic drugs in nursing homes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug interactions in the elderly. How multiple drug use increases risk exponentially

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iatrogenic causes of falls in hospitalised elderly patients: a case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioural symptoms in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532694

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200525080-00003

1 reference

Europe PubMed Central

3 November 2017

1 reference

Europe PubMed Central

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42622024&oldid=1963297212"